K233968 is an FDA 510(k) clearance for the CINA-iPE. Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.
Submitted by Avicenna.Ai (La Ciotat, FR). The FDA issued a Cleared decision on March 13, 2024 after a review of 89 days - a notably fast clearance cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Avicenna.Ai devices